1. Cell Biology
  2. Neuroscience
Download icon

Memory: Can fearlessness come in a tiny package?

  1. Bryan W Luikart  Is a corresponding author
  1. Dartmouth College, United States
Insight
  • Cited 0
  • Views 855
  • Annotations
Cite this article as: eLife 2017;6:e24575 doi: 10.7554/eLife.24575

Abstract

A molecule called microRNA-153 helps to prevent rats associating new environments with fear.

Main text

Contextual fear conditioning is a process that occurs when a painful or frightening stimulus happens within a specific context, and it can cause an individual to fear the context even when the stimulus is removed. In humans, it is thought that contextual fear conditioning can contribute to anxiety and post-traumatic stress disorder, so understanding how the brain forms “associative memories” that link a context to a traumatic event has been the subject of research for many years (Maren et al., 2013).

In rodents, we can study the neurobiological mechanisms responsible for the formation of such memories by pairing a painful stimulus with a new environment. If a rodent experiences an electrical shock after being placed in a new cage, it will associate that cage with the electrical shock. Thus, when the rodent is placed in the cage after this association has been established, it will become “frozen with fear” even if no shock is delivered.

Two regions of the brain – the amygdala and the hippocampus – have major roles in the formation of fear-associated memories. The experience of fear increases neuronal activity in several regions of the amygdala, and learning about a new environment increases activity in the hippocampus (Phillips and LeDoux, 1992). Stable associative memories are formed by changing the strength of the connections between neurons – called synapses – in these two regions.

To communicate across synapses, the presynaptic neuron releases neurotransmitters from membrane-enclosed compartments called vesicles in a process called exocytosis. The neurotransmitter molecules then travel across the synapse and bind to receptors on the surface of the postsynaptic neuron. The strength of the synapse can be changed by altering the ability of the presynaptic neuron to release neurotransmitters, or by altering the availability of the receptors on the postsynaptic neuron (Kessels and Malinow, 2009; Nicoll and Schmitz, 2005). Now, in eLife, Danesh Moazed of Harvard Medical School and colleagues – including Rebecca Mathew and Antonis Tatarakis as joint first authors – report that the synapses responsible for the formation of fear-associated memories are kept in check by a tiny molecule called microRNA-153 (Mathew et al., 2016).

MicroRNAs are short RNA molecules (Lee et al., 1993; Wightman et al., 1993) that interfere with the ability of messenger RNA molecules to encode proteins (Selbach et al., 2008). Mathew et al. – who are based at Harvard and a number of other institutes in the United States – identified a set of 21 microRNAs whose production is increased by fear conditioning in rats. In particular, they found that learning to associate fear with a new environment caused the expression of microRNA-153 to increase by a factor of approximately four in a part of the hippocampus called the dentate gyrus.

To determine whether microRNA-153 has a role in the formation of fear-associated memories Mathew et al. reduced its production in the hippocampus and performed fear conditioning experiments. They found that rats that were deficient in microRNA-153 froze more often in the cage where they had experienced an electrical shock. Thus, it appears that microRNA-153 decreases the formation of fear-associated memories.

To determine how microRNA-153 inhibits the formation of fear memories, Mathew et al. analyzed all of the genes that they had predicted would be regulated by fear-induced microRNAs. This sample included a large proportion of the genes involved in vesicle exocytosis, and microRNA-153 targeted a large number of these genes. Further investigation revealed that fear conditioning reduced the expression of the exocytosis-related genes, and microRNA-153 knockdown increased their expression.

Genes regulated by microRNA-153 (such as Snap25 and Pclo) control synaptic strength by regulating both presynaptic vesicle exocytosis and postsynaptic receptor trafficking (Jurado et al., 2013; Südhof, 2013). By demonstrating in vitro that manipulating the expression of microRNA-153 can also regulate these processes, Mathew et al. conclude that microRNA-153 counteracts the formation of associative memories during fear conditioning by decreasing the strength of synapses.

The results also lead to a number of new questions. Does microRNA-153 regulate the activity of the hippocampus more generally? And is microRNA-153 expression regulated in other brain regions, such as the amygdala, to modulate other aspects of fear?

It is also important to note that Mathew et al. found a total of 21 microRNAs whose production increased as a result of fear conditioning. Based on their sequence, these microRNAs are predicted to target genes involved in a number of processes: vesicle fusion, neuronal development, long-term potentiation, neurotransmission and synaptogenic adhesion. Thus, figuring out how these microRNAs influence memory formation is likely to involve a number of mechanisms that were not investigated by Mathew et al. Finally, as we gain insight into the roles that microRNAs play, it may be possible to leverage the properties of these tiny molecules to develop new treatments for anxiety and other disorders.

References

Article and author information

Author details

  1. Bryan W Luikart

    Geisel School of Medicine, Dartmouth College, Hanover, United States
    For correspondence
    Bryan.W.Luikart@dartmouth.edu
    Competing interests
    The author declares that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3181-6075

Publication history

  1. Version of Record published: February 6, 2017 (version 1)

Copyright

© 2017, Luikart

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 855
    Page views
  • 104
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cancer Biology
    2. Cell Biology
    Maxim I Maron et al.
    Research Article Updated

    Protein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I PRMT enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regulation, we inhibited Type I and II PRMTs and probed their transcriptomic consequences. Using the newly developed Splicing Kinetics and Transcript Elongation Rates by Sequencing (SKaTER-seq) method, analysis of co-transcriptional splicing demonstrated that PRMT inhibition resulted in altered splicing rates. Surprisingly, co-transcriptional splicing kinetics did not correlate with final changes in splicing of polyadenylated RNA. This was particularly true for retained introns (RI). By using actinomycin D to inhibit ongoing transcription, we determined that PRMTs post-transcriptionally regulate RI. Subsequent proteomic analysis of both PRMT-inhibited chromatin and chromatin-associated polyadenylated RNA identified altered binding of many proteins, including the Type I substrate, CHTOP, and the Type II substrate, SmB. Targeted mutagenesis of all methylarginine sites in SmD3, SmB, and SmD1 recapitulated splicing changes seen with Type II PRMT inhibition, without disrupting snRNP assembly. Similarly, mutagenesis of all methylarginine sites in CHTOP recapitulated the splicing changes seen with Type I PRMT inhibition. Examination of subcellular fractions further revealed that RI were enriched in the nucleoplasm and chromatin. Taken together, these data demonstrate that, through Sm and CHTOP arginine methylation, PRMTs regulate the post-transcriptional processing of nuclear, detained introns.

    1. Cell Biology
    2. Developmental Biology
    Omar Peña-Ramos et al.
    Research Article Updated

    Autophagosomes are double-membrane intracellular vesicles that degrade protein aggregates, intracellular organelles, and other cellular components. During the development of the nematode Caenorhabditis elegans, many somatic and germ cells undergo apoptosis. These cells are engulfed and degraded by their neighboring cells. We discovered a novel role of autophagosomes in facilitating the degradation of apoptotic cells using a real-time imaging technique. Specifically, the double-membrane autophagosomes in engulfing cells are recruited to the surfaces of phagosomes containing apoptotic cells and subsequently fuse to phagosomes, allowing the inner vesicle to enter the phagosomal lumen. Mutants defective in the production of autophagosomes display significant defects in the degradation of apoptotic cells, demonstrating the importance of autophagosomes to this process. The signaling pathway led by the phagocytic receptor CED-1, the adaptor protein CED-6, and the large GTPase dynamin (DYN-1) promotes the recruitment of autophagosomes to phagosomes. Moreover, the subsequent fusion of autophagosomes with phagosomes requires the functions of the small GTPase RAB-7 and the HOPS complex components. Further observations suggest that autophagosomes provide apoptotic cell-degradation activities in addition to and in parallel of lysosomes. Our findings reveal that, unlike the single-membrane, LC3-associated phagocytosis (LAP) vesicles reported for mammalian phagocytes, the canonical double-membrane autophagosomes facilitate the clearance of C. elegans apoptotic cells. These findings add autophagosomes to the collection of intracellular organelles that contribute to phagosome maturation, identify novel crosstalk between the autophagy and phagosome maturation pathways, and discover the upstream signaling molecules that initiate this crosstalk.